Premier submitted a statement for the Nov. 8 Senate Health, Education, Labor and Pensions Subcommittee on Primary Health and Retirement Security hearing
entitled, “Avoiding a Cautionary Tale: Policy Considerations for Artificial Intelligence in Health Care.” Premier shared its advocacy roadmap for artificial intelligence (AI) and identified several opportunities for Congressional and/or administrative involvement in AI governance, including:
- Holding AI technology in healthcare accountable to standardized, outcomes-focused metrics that take into account the fact that this novel technology is intended to evolve and learn;
- Advancing AI risk assessments that inform targeted mitigation strategies aimed at protecting patients and their data;
- Clarifying statutory and regulatory frameworks to harness AI to streamline processes and expand patient access in clinical trials;
- Promoting the use of AI in drug manufacturing to improve supply chain visibility and quality and process control; and
- Training the healthcare workforce on AI literacy to combat automation bias and related issues as clinicians continue to leverage AI to assist (but not replace) the practice of medicine.